The genetic profile of a neurofibromatosis type 1 Vietnamese patient with complicated pheochromocytomas and colorectal tumors

Abstract

Neurofibromatosis type 1 (NF1) is a hereditary, autosomal dominant condition marked by the development of tumors along the nervous system due to uncontrolled cell proliferation. The current case reports a 31-year-old male patient diagnosed with NF1 with the involvement of bilateral pheochromocytomas and colonic inflammatory polyps/leiomyoma. A genetic profile was explored through whole-exome sequencing to identify pathogenic variants, and segregation analysis was subsequently performed in the patient’s family. Sequencing analysis revealed a novel heterozygous frameshift variant, NF1 c.7301dupA (p.S2435Efs*11), which was identified as the pathogenic variant in the patient. Additionally, two identified variants, PMS2 c.2T>C (p.M1T) and MUTYH c.850-2A>G, may be associated with colonic tumor conditions in the patient. These findings provide insights into the molecular etiology underlying this rare presentation of multiple tumors in a Vietnamese male and may contribute to improved treatment planning and patient management.

Keywords

Neurofibromatosis type 1 / pheochromocytoma / colorectal tumor

References

[1] Brems H,Beert E,de Ravel T,Legius E.Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.Lancet Oncol.2009;10:508-15.

[2] Neurofibromatosis: Conference Statement.Arch Neurol.1988;45:575-8.

[3] Jett K,Friedman JM.Clinical and genetic aspects of neurofibromatosis 1.Genet Med.2010;12:1-11.

[4] Tonsgard JH.Clinical manifestations and management of neurofibromatosis type 1.Semin Pediatr Neurol.2006;13:2-7.

[5] Hirbe AC,Gutmann DH.Neurofibromatosis type 1: a multidisciplinary approach to care.Lancet Neurol.2014;13:834-43.

[6] Shang L,Fang Z,Liu J,Du F,Jing H,Xu Y,et al.Case report of ascending colon cancer and multiple jejunal GISTs in a patient with neurofibromatosis type 1 (NF1).BMC Cancer.2019;19:1196.

[7] Zografos GN,Vasiliadis GK,Zagouri F,Aggeli C,Korkolis D,Vogiaki S,et al.Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.World J Surg Oncol.2010;8:14.

[8] Hungerford CH,Hughes PR.Do individuals with NF1 benefit from colon cancer screening at an earlier age?Evidence-Based Pract.2021;24:22-3.

[9] Zinnamosca L,Petramala L,Cotesta D,Marinelli C,Schina M,Cianci R,et al.Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects.Arch Dermatol Res.2011;303:317-25.

[10] Hernandez FC,Sánchez M,Alvarez A,Díaz J,Pascual R,Pérez M,et al.A five-year report on experience in the detection of pheochromocytoma.Clin Biochem.2000;33:649-55.

[11] Tsuchiya T,Iwaya Y,Iwaya M,Okamura T,Nagaya T,Umemura T.A Case of Multiple Perineuriomas in the Colon With Underlying Neurofibromatosis Type I.ACG Case Rep J.2021;8:e00665.

[12] Oktenli C,Gul D,Deveci MS,Saglam M,Upadhyaya M,Thompson P,et al.Unusual features in a patient with neurofibromatosis type 1: multiple subcutaneous lipomas, a juvenile polyp in ascending colon, congenital intrahepatic portosystemic venous shunt, and horseshoe kidney.Am J Med Genet A.2004;127A:298-301.

[13] Richards S,Aziz N,Bale S,Bick D,Das S,Gastier-Foster J,et al.ACMG Laboratory Quality Assurance Committee.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.Genet Med.2015;17:405-24.

[14] Mo J,Moye SL,McKay RM,Le LQ.Neurofibromin and suppression of tumorigenesis: beyond the GAP.Oncogene.2022;41:1235-51.

[15] Bostancı MT,Yılmaz İ,Saydam M,Seki A.Solitary Juvenile Colonic Polyp Presenting Anaemia in Patients with Neurofibromatosis Type 1: A Case Report.Turk J Colorectal Dis.2020;30:147-50.

[16] Krüger S,Kinzel M,Walldorf C,Gottschling S,Bier A,Tinschert S,et al.Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.Eur J Hum Genet.2008;16:62-72.

[17] Sehgal R,Sheahan K,O’Connell PR,Hanly AM,Martin ST,Winter DC.Lynch syndrome: an updated review.Genes (Basel).2014;5:497-507.

[18] Tian X,Wang Q,Cai W.A Novel Mutation in MYH Gene Associated with Aggressive Colorectal Cancer in a Child: A Case Report and Review of Literature.Onco Targets Ther.2020;13:8557-65.